Lv3
330 积分 2022-09-27 加入
Anti-PD-1 antibody combined with albumin-bound paclitaxel and gemcitabine (AG) as first-line therapy and Anti-PD-1 monotherapy as maintenance in metastatic pancreatic ductal adenocarcinoma (PDAC)
2天前
求助中
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
1个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
2个月前
已完结
Managing toxicities associated with immune checkpoint inhibitors
2个月前
已完结
Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer
2个月前
已完结
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
2个月前
已完结
Therapeutic developments in pancreatic cancer
3个月前
已完结
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
3个月前
已完结
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
3个月前
已完结
Immune Checkpoint Inhibitor-Related Pneumonitis
5个月前
已完结
皖公网安备34019202002308
